Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.
暂无分享,去创建一个
Eyal Dassau | Francis J Doyle | Howard C Zisser | Dale E Seborg | F. Doyle | D. Seborg | E. Dassau | H. Zisser | L. Jovanovic | W. Bevier | R. A. Harvey | Wendy C Bevier | Lois Jovanovič | Rebecca A Harvey
[1] V. Basevi,et al. Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.
[2] Eyal Dassau,et al. Modular Artificial β-Cell System: A Prototype for Clinical Research , 2008 .
[3] Eyal Dassau,et al. Proposed Clinical Application for Tuning Fuzzy Logic Controller of artificial Pancreas Utilizing a Personalization Factor , 2010, Journal of diabetes science and technology.
[4] Aesha Drozdowski,et al. Standards of medical care in diabetes. , 2004, Diabetes care.
[5] Nicholas A. Peppas,et al. Model predictive control for infusion pump insulin delivery , 1996, Proceedings of 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[6] R.S. Parker,et al. A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.
[7] S. Patek,et al. Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experience , 2009, Journal of diabetes science and technology.
[8] Howard C. Zisser,et al. Fully Integrated Artificial Pancreas in Type 1 Diabetes , 2012, Diabetes.
[9] G. Steil,et al. Closed-Loop Insulin Therapy Improves Glycemic Control in Children Aged <7 Years , 2013, Diabetes Care.
[10] Janet M. Allen,et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies , 2011, BMJ : British Medical Journal.
[11] F. El-Khatib,et al. A Feasibility Study of Bihormonal Closed-Loop Blood Glucose Control Using Dual Subcutaneous Infusion of Insulin and Glucagon in Ambulatory Diabetic Swine , 2009, Journal of diabetes science and technology.
[12] E. Atlas,et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. , 2013, The New England journal of medicine.
[13] Ahmad Haidar,et al. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial , 2013, Canadian Medical Association Journal.
[14] C. Larizza,et al. Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients. , 2003, Diabetes technology & therapeutics.
[15] L. Magni,et al. Multinational Study of Subcutaneous Model-Predictive Closed-Loop Control in Type 1 Diabetes Mellitus: Summary of the Results , 2010, Journal of diabetes science and technology.
[16] G. Steil,et al. Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.
[17] E. Atlas,et al. MD-Logic Artificial Pancreas System , 2010, Diabetes Care.
[18] Howard C. Zisser,et al. Clinical Evaluation of a Personalized Artificial Pancreas , 2013, Diabetes Care.
[19] M. Karvonen,et al. The effects of training on heart rate; a longitudinal study. , 1957, Annales medicinae experimentalis et biologiae Fenniae.
[20] Anirban Roy,et al. The effect of insulin feedback on closed loop glucose control. , 2011, The Journal of clinical endocrinology and metabolism.
[21] Dale E. Seborg,et al. Control-Relevant Models for Glucose Control Using A Priori Patient Characteristics , 2012, IEEE Transactions on Biomedical Engineering.
[22] L. Magni,et al. Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier , 2009, Journal of diabetes science and technology.
[23] J. Leahy,et al. Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .
[24] J. Stockman,et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2011 .
[25] Eyal Dassau,et al. Zone Model Predictive Control: A Strategy to Minimize Hyper- and Hypoglycemic Events , 2010, Journal of diabetes science and technology.
[26] F. Doyle,et al. Design of the Health Monitoring System for the Artificial Pancreas: Low Glucose Prediction Module , 2012, Journal of diabetes science and technology.
[27] W. Kenneth Ward,et al. Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.
[28] Irl B Hirsch,et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[29] W. Clarke. The original Clarke Error Grid Analysis (EGA). , 2005, Diabetes technology & therapeutics.
[30] Marc D. Breton,et al. Modular Closed-Loop Control of Diabetes , 2012, IEEE Transactions on Biomedical Engineering.
[31] Robert G. Sutherlin,et al. A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.
[32] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[33] Eyal Dassau,et al. Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes , 2012, Diabetes Care.